impact factor
logo
 

2015 Vol.33, N°5 - Suppl.93 - Table of contents

Psoriatic Arthritis

Psoriatic Arthritis

Guest Editors: T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

 

purchase complete issue

Introduction

CER9050
2015,33,5,Suppl.93
Pg. 0001

Free to view

Psoriatic arthritis
T. Pincus, J. Braun, A. Kavanaugh, J.S. Smolen

Rheumatology Abstract

Rheumatology Article

Skin and nail manifestations in psoriatic arthritis

CER8924
2015,33,5,Suppl.93
Pg. 0002-0006

Free to view

Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine
W. Alwan, F.O. Nestle

Rheumatology Abstract

Rheumatology Article

 

CER8922
2015,33,5,Suppl.93
Pg. 0007-0013

Free to view

Nail psoriasis
R. Manhart, P. Rich

Rheumatology Abstract

Rheumatology Article

 

CER9009
2015,33,5,Suppl.93
Pg. 0014-0019

Free to view

The skin in psoriasis: assessment and challenges
V. Oji, T.A. Luger

Rheumatology Abstract

Rheumatology Article

Musculoskeletal manifestations of psoriatic arthritis

CER9008
2015,33,5,Suppl.93
Pg. 0020-0025

Free to view

The joint in psoriatic arthritis
M. Mortezavi, R. Thiele, C. Ritchlin

Rheumatology Abstract

Rheumatology Article

 

CER8901
2015,33,5,Suppl.93
Pg. 0026-0030

Free to view

Peripheral joint involvement in psoriatic arthritis patients
M.L. Acosta Felquer, O. Fitzgerald

Rheumatology Abstract

Rheumatology Article

 

CER8882
2015,33,5,Suppl.93
Pg. 0031-0035

Free to view

The involvement of the spine in psoriatic arthritis
X. Baraliakos, L.C. Coates, J. Braun

Rheumatology Abstract

Rheumatology Article

 

CER8920
2015,33,5,Suppl.93
Pg. 0036-0039

Free to view

The enthesis in psoriatic arthritis
D. Mcgonagle, A.L. Tan

Rheumatology Abstract

Rheumatology Article

 

CER8986
2015,33,5,Suppl.93
Pg. 0040-0043

Free to view

The conundrum of juvenile psoriatic arthritis
A. Ravelli, A. Consolaro, B. Schiappapietra, A. Martini

Rheumatology Abstract

Rheumatology Article

Assessment of psoriatic arthritis

CER8878
2015,33,5,Suppl.93
Pg. 0044-0047

Free to view

Assessment of disease activity in psoriatic arthritis
P.S. Helliwell

Rheumatology Abstract

Rheumatology Article

 

CER8891
2015,33,5,Suppl.93
Pg. 0048-0050

Free to view

Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review
J.S. Smolen, M. Schoels, D. Aletaha

Rheumatology Abstract

Rheumatology Article

 

CER8865
2015,33,5,Suppl.93
Pg. 0051-0054

Free to view

An overview of low disease activity and remission in psoriatic arthritis
E. Lubrano, F.M. Perrotta, A. Kavanaugh

Rheumatology Abstract

Rheumatology Article

Imaging in psoriatic arthritis

CER8971
2015,33,5,Suppl.93
Pg. 0055-0059

Free to view

Radiographic scoring methods in psoriatic arthritis
S. Wassenberg

Rheumatology Abstract

Rheumatology Article

 

CER8820
2015,33,5,Suppl.93
Pg. 0060-0065

Free to view

Psoriatic arthritis: what ultrasound can provide us
A. Delle Sedie, L. Riente

Rheumatology Abstract

Rheumatology Article

 

CER8781
2015,33,5,Suppl.93
Pg. 0066-0069

Free to view

Magnetic resonance imaging for diagnosing, monitoring and prognostication in psoriatic arthritis
R.P. Poggenborg, I.J. Sørensen, S.J. Pedersen, M. Østergaard

Rheumatology Abstract

Rheumatology Article

Approach to therapy of psoriatic arthritis

CER8877
2015,33,5,Suppl.93
Pg. 0070-0072

Free to view

Therapy strategies in psoriatic arthritis
L.C. Coates

Rheumatology Abstract

Rheumatology Article

 

CER8886
2015,33,5,Suppl.93
Pg. 0073-0077

Free to view

Treatment of psoriatic arthritis: management recommendations
L. Gossec, J.S. Smolen

Rheumatology Abstract

Rheumatology Article

 

CER8923
2015,33,5,Suppl.93
Pg. 0078-0081

Free to view

Skin therapies: dermatologic perspective on the rheumatology-dermatology interface
J.L. Sasaki, J.Y. Koo

Rheumatology Abstract

Rheumatology Article

 

CER9016
2015,33,5,Suppl.93
Pg. 0082-0093

Free to view

Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
T. Pincus, M.J. Bergman, Y. Yazici

Rheumatology Abstract

Rheumatology Article

Targeted systemic DMARDs in psoriatic arthritis

CER8987
2015,33,5,Suppl.93
Pg. 0094-0097

Free to view

The role of methotrexate in psoriatic arthritis: what is the evidence?
I. Ianculescu, M.H. Weisman

Rheumatology Abstract

Rheumatology Article

 

CER9003
2015,33,5,Suppl.93
Pg. 0098-0100

Free to view

Apremilast in psoriatic arthritis
G. Schett

Rheumatology Abstract

Rheumatology Article

 

CER8995
2015,33,5,Suppl.93
Pg. 0101-0103

Free to view

Cyclosporine in psoriatic arthropathy
A. Soriano, N. Pipitone, C. Salvarani

Rheumatology Abstract

Rheumatology Article

Biological agents in psoriatic arthritis

CER9000
2015,33,5,Suppl.93
Pg. 0104-0108

Free to view

A short history of biological therapy for psoriatic arthritis
P. Mease

Rheumatology Abstract

Rheumatology Article

 

CER8956
2015,33,5,Suppl.93
Pg. 0109-0114

Free to view

Anti-TNFα-therapy as an evidence-based treatment option for different clinical manifestations of psoriatic arthritis
M. Köhm, H. Burkhardt, F. Behrens

Rheumatology Abstract

Rheumatology Article

 

CER8919
2015,33,5,Suppl.93
Pg. 0115-0118

Free to view

Interleukin-12 and interleukin-23 inhibition in psoriatic arthritis
H.J. Johnsson, I.B. Mcinnes

Rheumatology Abstract

Rheumatology Article

 

CER8879
2015,33,5,Suppl.93
Pg. 0119-0123

Free to view

Interleukin-17 inhibition in psoriatic arthritis
T. Boyd, A. Kavanaugh

Rheumatology Abstract

Rheumatology Article

Continuing Medical Education Activity

CER9138
2015,33,5,Suppl.93
Pg. 0124-0126

Free to view

Continuing Medical Education Evaluation
No Author

Rheumatology Abstract

Rheumatology Article